2916 participants
Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-12-09
- Start Date:
- 2019-01-01
- Completion:
- 2031-12-31
Conditions
- HER2-positive Breast Cancer
No Results Yet